Katie Quinn

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)